论文信息 - OP23 Efficacy and safety of vedolizumab SC in patients with moderately to severely active Crohn’s disease: Results of the VISIBLE 2 study - 字舞流文

OP23 Efficacy and safety of vedolizumab SC in patients with moderately to severely active Crohn’s disease: Results of the VISIBLE 2 study

S. Vermeire | G. D'Haens | F. Baert | E. Loftus | S. Danese | W. Zhang | M. Rosario | S. Bhatia | W. Sandborn | K. Kisfalvi | T. Kobayashi